Mersana Therapeutics Inc (MRSN) — Cash Flow Quality Index

Latest as of March 2019: -1.13x

Mersana Therapeutics Inc (MRSN) has a Cash Flow Quality Index of -1.13x as of March 2019. Operating cash flow of $-24.69 Million is below net income of $21.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Mersana Therapeutics Inc (MRSN) investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.13x

Operating CF / Net Income

Operating Cash Flow

$-24.69 Million

USD

Net Income

$21.90 Million

USD

Data as of

Mar 2019

Most recent filing

Annual Cash Flow Quality Index for Mersana Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Mersana Therapeutics Inc. For live market cap and the full company financial profile, see MRSN market cap overview.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.